BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2015
View Archived Issues
KemPharm updates pipeline progress
Read More
Xenon initiates phase I trial of XEN-801 for acne
Read More
Resverlogix to explore apabetalone for complement-mediated diseases
Read More
Syros in-licenses tamibarotene and plans phase II trial in AML and MDS
Read More
CIRM grants USD 19.9 million to ImmunoCellular for the funding of ICT-107
Read More
Novo Nordisk discloses results from second phase IIIa trial of semaglutide in type 2 diabetes
Read More
Arrowhead reports phase II and preclinical results for siRNA therapies targeting HBV
Read More
AbbVie passes on Galapagos' filgotinib, plans to advance own JAK1 inhibitor to phase III
Read More
Fungal CYP51 inhibitors to overcome resistance
Read More
SNRI Effexor SR Capsules obtained approval in Japan
Read More
Microlin releases study results of anti-microRNA candidate in murine lung cancer model
Read More
EMA committee recommends approval of Numient for Parkinson's disease
Read More
FDA grants priority review to sBLA for nivolumab + ipilimumab regimen in untreated advanced melanoma
Read More
FDA gives fast track designation to OpRegen for dry AMD
Read More
Ocular Therapeutix submits NDA for Dextenza
Read More
GlaxoSmithKline's Zagallo receives approval in Japan
Read More
Interim results from a phase II study on oral Relugolix in prostate cancer patients
Read More
Shionogi's Mulpleta approved in Japan for thrombocytopenia
Read More
Verastem stops COMMAND study of VS-6063 in mesothelioma for futility
Read More
Columbia University in the City of New York patents MOR-1 agonists
Read More
Takeda Pharmaceutical reports development of acyl-CoA desaturase inhibitors
Read More
AbbVie Deutschland discloses 5-HT2C receptor agonists
Read More
Icahn School of Medicine at Mount Sinai describes PP2A activators
Read More
Eribulin sNDA for inoperable soft tissue sarcoma gets FDA grants priority review
Read More
FORUM Pharmaceuticals presents gamma-secretase modulators
Read More
Selumetinib plus HAART is effective in advanced HIV-associated Karposi's sarcoma
Read More
FDA accepts for filing Ontinua ER NDA
Read More
Tepotinib and gefitinib combination active in c-Met-positive EGFR mutant NSCLC asian patients
Read More
New results for epacadostat in combination with ipilimumab for the treatment of melanoma
Read More